This finding is not unusual since many investigations [51,52,53] collectively demonstrated that mutation of APC, AXIN2 or beta-catenin are rarely seen in lung cancer [53,54] or are mutually exclusive, which is supported by our results. This evidence concerns the gene AXIN2 and lung carcinoma.